Informed-money record

ARQT · Arcutis Biotherapeutics, Inc.

Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.

Bullish filings

Bearish filings

149

Named actors

Disclosed $ (bull / bear)

$16K / $34.4M

Recent disclosures

25 of 152 in the window · linked to source

Date	Who	What	Disclosed $	Receipt
2026-08-27	Director (via Merrill Lynch) Terrie Curran	filed notice to sell	$956K	SEC ↗
2026-08-27	Director Curran Terrie	sold	$677K	SEC ↗
2026-08-27	Director Curran Terrie	sold	$279K	SEC ↗
2026-08-20	Director (via Merrill Lynch) Terrie Curran	filed notice to sell	$28K	SEC ↗
2026-08-20	Director Curran Terrie	sold	$28K	SEC ↗

127 more disclosures in the window — the full record, scoring, and validation are for members.

Want the read, not just the record?

Members see how notable each move is, whether the actor's track record validates, cross-source convergence, and alerts on this name.

Create a free account →

Dispute or correct this record

Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals